Business Description
Zenith Drugs Ltd
ISIN : INE0QWN01013
Compare
Compare
Traded in other countries / regions
ZENITHDRUG.India IPO Date
2024-02-27Description
Zenith Drugs Ltd is a pharmaceutical manufacturing and trading company. It offers a wide range of formulations in various forms such as ORS Powder, Liquid Orals, Ointments, Liquid Externals, and Capsules. It is also into Generic Medicines.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.02 | |||||
| Equity-to-Asset | 0.47 | |||||
| Debt-to-Equity | 0.58 | |||||
| Debt-to-EBITDA | 2.67 | |||||
| Interest Coverage | 6.72 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 3.21 | |||||
| Beneish M-Score | -1.36 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 21.5 | |||||
| 3-Year EBITDA Growth Rate | 32.4 | |||||
| 3-Year EPS without NRI Growth Rate | 48.7 | |||||
| 3-Year FCF Growth Rate | -201 | |||||
| 3-Year Book Growth Rate | 90.9 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 92.15 | |||||
| 9-Day RSI | 80.36 | |||||
| 14-Day RSI | 69.34 | |||||
| 6-1 Month Momentum % | 38.5 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.82 | |||||
| Quick Ratio | 1.33 | |||||
| Cash Ratio | 0.02 | |||||
| Days Inventory | 110.26 | |||||
| Days Sales Outstanding | 178.19 | |||||
| Days Payable | 168.73 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.52 | |||||
| Dividend Payout Ratio | 0.08 | |||||
| Forward Dividend Yield % | 0.52 | |||||
| 5-Year Yield-on-Cost % | 0.52 | |||||
| Shareholder Yield % | -2.12 |
Profitability Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 28.68 | |||||
| Operating Margin % | 9.6 | |||||
| Net Margin % | 7.63 | |||||
| FCF Margin % | -32.43 | |||||
| ROE % | 19.44 | |||||
| ROA % | 7.6 | |||||
| ROIC % | 13.16 | |||||
| 3-Year ROIIC % | 12.07 | |||||
| ROC (Joel Greenblatt) % | 19.05 | |||||
| ROCE % | 21.53 | |||||
| Years of Profitability over Past 10-Year | 4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 17.4 | |||||
| PE Ratio without NRI | 16.18 | |||||
| PS Ratio | 1.33 | |||||
| PB Ratio | 2.54 | |||||
| Price-to-Tangible-Book | 2.41 | |||||
| EV-to-EBIT | 13.15 | |||||
| EV-to-EBITDA | 11.93 | |||||
| EV-to-Revenue | 1.36 | |||||
| EV-to-FCF | -4.39 | |||||
| Price-to-Graham-Number | 1.28 | |||||
| Price-to-Net-Current-Asset-Value | 4.96 | |||||
| Earnings Yield (Greenblatt) % | 7.6 | |||||
| FCF Yield % | -25.73 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Zenith Drugs Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 1,299.052 | ||
| EPS (TTM) (₹) | 5.772 | ||
| Beta | 0 | ||
| Volatility % | 0 | ||
| 14-Day RSI | 69.34 | ||
| 14-Day ATR (₹) | 4.440931 | ||
| 20-Day SMA (₹) | 86.145 | ||
| 12-1 Month Momentum % | 0 | ||
| 52-Week Range (₹) | 52.8 - 154.4 | ||
| Shares Outstanding (Mil) | 17.15 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Zenith Drugs Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Zenith Drugs Ltd Stock Events
| Event | Date | Price(₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Zenith Drugs Ltd Frequently Asked Questions
What is Zenith Drugs Ltd(NSE:ZENITHDRUG)'s stock price today?
The current price of NSE:ZENITHDRUG is ₹95.45. The 52 week high of NSE:ZENITHDRUG is ₹154.40 and 52 week low is ₹52.80.
When is next earnings date of Zenith Drugs Ltd(NSE:ZENITHDRUG)?
The next earnings date of Zenith Drugs Ltd(NSE:ZENITHDRUG) is .
Does Zenith Drugs Ltd(NSE:ZENITHDRUG) pay dividends? If so, how much?
The Dividend Yield %  of Zenith Drugs Ltd(NSE:ZENITHDRUG) is 0.52% (As of Today), Highest Dividend Payout Ratio of Zenith Drugs Ltd(NSE:ZENITHDRUG) was 0.08. The lowest was 0. And the median was 0. The  Forward Dividend Yield % of Zenith Drugs Ltd(NSE:ZENITHDRUG) is 0.52%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers